☆ 4.7 Editorial Material

ASO Author Reflections: Repeated Intraperitoneal Paclitaxel with Systemic Chemotherapy as the First-Line Treatment for Peritoneal Malignancy

ANNALS OF SURGICAL ONCOLOGY (2021)

期刊

ANNALS OF SURGICAL ONCOLOGY

卷 28, 期 7, 页码 3871-3872

出版社

SPRINGER

DOI: 10.1245/s10434-020-09417-2

关键词

-

类别

Oncology Surgery

资金

Japan Society for the Promotion of Science [17H04286]
Grants-in-Aid for Scientific Research [17H04286] Funding Source: KAKEN

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases

Daryl K. A. Chia, Raghav Sundar, Guowei Kim, Jia Jun Ang, Jeffrey H. Y. Lum, Min En Nga, Giap Hean Goh, Ju Ee Seet, Cheng Ean Chee, Hon Lyn Tan, Jingshan Ho, Natalie Y. L. Ngoi, Matilda X. W. Lee, Vaishnavi Muthu, Gloria H. J. Chan, Angela S. L. Pang, Yvonne L. E. Ang, Joan R. E. Choo, Joline S. J. Lim, Jun Liang Teh, Aung Lwin, Yuen Soon, Asim Shabbir, Jimmy B. Y. So, Wei Peng Yong

Summary: This study aimed to evaluate the use of IP-PTX with XELOX for GCPM. Compared with the SC group, the IP group achieved better results in overall survival and progression-free survival. In the IP group, patients who underwent conversion surgery had a median overall survival of 24.2 months and a 1-year overall survival rate of 84.6%.

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis

Eeeln Buckarma, Cornelius A. Thiels, Zhaohui Jin, Travis E. Grotz

Summary: CRS and HIPEC with paclitaxel and cisplatin is well tolerated and associated with favorable oncologic and perioperative outcomes.

ANNALS OF SURGICAL ONCOLOGY (2023)

添加到收藏夹

Article Oncology

Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis-STOPGAP trial

Maheswari Senthil, Farshid Dayyani

Summary: This study aims to assess the 1-year progression-free survival benefit of sequential systemic chemotherapy followed by paclitaxel intraperitoneal chemotherapy (NIPEC) in patients with gastric peritoneal carcinomatosis (PC). It is a single center, single arm, phase II trial. The primary endpoint is 1-year progression-free survival.

BMC CANCER (2023)

添加到收藏夹

Article Oncology

Safety and Efficacy of Intraperitoneal Paclitaxel Plus Intravenous Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX) for Gastric Cancer with Peritoneal Metastasis

So Hyun Kang, Sa-Hong Min, Jin Won Kim, Eunju Lee, Sang Woo Park, Sangjun Lee, Hyeon Jeong Oh, Young Suk Park, Yoon Jin Lee, Ji-Won Kim, Sang-Hoon Ahn, Yun-Suhk Suh, Keun-Wook Lee, Hye Seung Lee, Hyung-Ho Kim

Summary: This study aimed to determine the recommended phase II dose for gastric cancer patients through intraperitoneal paclitaxel combined with intravenous fluorouracil, leucovorin, and oxaliplatin. The results showed that this treatment regimen is safe, and the recommended phase II dose of IP paclitaxel is 60 mg/m(2).

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Editorial Material Oncology

ASO Author Reflections: Indolent Growth and Small Bowel Neuroendocrine Tumor Management

S. K. Sherman, C. G. Tran, J. R. Howe

Summary: Surgical treatment is central to managing small bowel neuroendocrine tumors, but current controversies and obstacles exist. With increasing referral of patients to high-volume centers, cooperation between experienced clinicians should allow for the design of high-quality randomized trials to answer key questions.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Review Oncology

A Review of the Use of Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy in Pediatric Patients

David J. J. Byrwa, Clare J. J. Twist, Joseph Skitzki, Elizabeth Repasky, P. Ben Ham, Ajay Gupta

Summary: Hyperthermic intraperitoneal chemotherapy (HIPEC) is a treatment method that targets microscopic peritoneal disease. This review focuses on HIPEC in pediatrics, discussing chemotherapy choice, post-operative morbidity and mortality, and impact on overall survival. Although HIPEC with cisplatin is generally well-tolerated with minimal complications, its effect on survival compared to systemic chemotherapy and debulking surgery is uncertain.

CANCERS (2023)

添加到收藏夹

Article Surgery

Efficacy of conversion surgery after a single intraperitoneal administration of paclitaxel and systemic chemotherapy for gastric cancer with peritoneal metastasis

Masayuki Shinkai, Motohiro Imano, Yoko Hiraki, Kota Momose, Hiroaki Kato, Osamu Shiraishi, Atsushi Yasuda, Masanobu Tsubaki, Shozo Nishida, Takushi Yasuda

Summary: Conversion surgery is safe and may prolong survival for gastric cancer patients with peritoneal metastasis who have responded to single i.p. PTX plus systemic chemotherapy.

LANGENBECKS ARCHIVES OF SURGERY (2022)

添加到收藏夹

Article Oncology

Cost-analysis of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal malignancy: An Australian perspective with global application

Kate E. McBride, Daniel Steffens, Michael J. Solomon, Cherry Koh, Nabila Ansari, Christopher J. Young, Brendan Moran

Summary: This study analyzed the in-hospital costs of CRS and HIPEC in comparison to an Australian ABF system, finding that surgical staff proficiency can reduce total costs and that surgical time, ICU stay, and hospital stay are major predictors of costs.

EJSO (2021)

添加到收藏夹

Article Oncology

A phase I study of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel for pancreatic cancer with peritoneal metastasis

Naminatsu Takahara, Yousuke Nakai, Hironori Ishigami, Kei Saito, Tatsuya Sato, Ryunosuke Hakuta, Kazunaga Ishigaki, Tomotaka Saito, Tsuyoshi Hamada, Suguru Mizuno, Hirofumi Kogure, Hiroharu Yamashita, Hiroyuki Isayama, Yasuyuki Seto, Kazuhiko Koike

Summary: This study investigated the maximum tolerated dose and recommended dose of intraperitoneal paclitaxel combined with gemcitabine plus nab-paclitaxel in pancreatic cancer patients with peritoneal metastasis. The results showed the feasibility and potential effectiveness of this treatment regimen as a first-line therapy for pancreatic cancer patients with peritoneal metastasis.

INVESTIGATIONAL NEW DRUGS (2021)

添加到收藏夹

Article Medicine, General & Internal

Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO

Job P. van Kooten, Michelle Dietz, Niels A. D. Guchelaar, Alexandra R. M. Brandt-Kerkhof, Stijn L. W. Koolen, Jacobus W. A. Burger, Ron H. J. Mathijssen, Cornelis Verhoef, Joachim G. J. Aerts, Eva V. E. Madsen

Summary: Malignant peritoneal mesothelioma (MPM) is a rare and aggressive tumor, and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is the only potential curative treatment. However, most patients are not eligible for this treatment, highlighting the need for palliative options. This study aims to determine the maximum tolerable dose of intraperitoneal paclitaxel monotherapy in MPM patients and assess its safety and pharmacokinetics.

BMJ OPEN (2022)

添加到收藏夹

Article Oncology

Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases

Nicolas Tabchouri, Jonathan Buggisch, Cedric Remy Demtroeder, Julien Thiery, Gunther Rezniczek, Clemens B. Tempfer, Britta Fischer, Can Dogan, Thierry Lecomte, Mehdi Ouaissi, Urs Giger-Pabst

Summary: The study demonstrated that repetitive pressurized intraperitoneal aerosol chemotherapy (PIPAC-Ox) for patients with non-resectable colorectal peritoneal metastases (CPM) is feasible, especially with three or more consecutive cycles showing improvement in survival rates.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer

Loek A. W. de Jong, Marie Lambert, Nielka P. van Erp, Lukas de Vries, Etienne Chatelut, Petronella B. Ottevanger

Summary: The purpose of this study was to determine the systemic exposure to cisplatin and paclitaxel following adjuvant intraperitoneal administration in patients with advanced ovarian cancer. The study found that systemic exposure to cisplatin after intraperitoneal administration is high, providing a pharmacological explanation for the high incidence of adverse events seen with this treatment regimen.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2023)

添加到收藏夹

Editorial Material Oncology

ASO Author Reflections: The Evolution of Surgery for Patients with Stage IV Melanoma

Thinzar Lwin, George Molina, Genevieve Boland

Summary: The role of surgery in stage IV melanoma patients is changing rapidly. In the past, surgery was only offered to carefully selected patients due to limited treatment options. With the advent of effective immunotherapy, the role of surgery is still being defined. This study examines the outcomes of stage IV melanoma patients who received immunotherapy and surgery, and future research will help identify the appropriate patients and timing of surgery in the context of expanding therapeutic options.

ANNALS OF SURGICAL ONCOLOGY (2023)

添加到收藏夹

Editorial Material Oncology

ASO Author Reflections: Endoscopic Management is Reasonable for <2 cm Duodenal Neuroendocrine Tumors

Catherine G. Tran, Scott K. Sherman, James R. Howe

Summary: The optimal management of duodenal neuroendocrine tumors (DNETs) has not been well-defined, especially for DNETs 1-2 cm in size. Recent studies have shown that endoscopic mucosal resection (EMR) is a safe and effective option for these intermediate-sized DNETs, which may lead to updates in expert and consensus guidelines.

ANNALS OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence

Enrico Maria Pasqual, Ambrogio P. Londero, Manuela Robella, Marco Tonello, Antonio Sommariva, Michele De Simone, Stefano Bacchetti, Gianluca Baiocchi, Salvatore Asero, Federico Coccolini, Franco De Cian, Marcello Guaglio, Armando Cinquegrana, Carola Cenzi, Stefano Scaringi, Antonio Macri

Summary: In this multicentric study, there was no increase in complications after the second or third CRS procedure combined with HIPEC for peritoneal metastases. Encouraging survival results were observed, indicating the safety and efficacy of repeated CRS and HIPEC.

CANCERS (2023)

添加到收藏夹

Article Oncology

Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced Gastric Cancer with Peritoneal Metastases

Shin Saito, Hironori Yamaguchi, Hideyuki Ohzawa, Hideyo Miyato, Rihito Kanamaru, Kentaro Kurashina, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama

Summary: The combination chemotherapy using SOX + IP-PTX regimen showed high efficacy in patients with peritoneal metastases from gastric cancer, with a 1-year overall survival rate of 79.5%. Common toxicities included neutropenia, leukopenia, and anemia, but there were no treatment-related deaths.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Article Medical Laboratory Technology

Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer

Kazuya Takahashi, Kentaro Kurashina, Shin Saito, Rihito Kanamaru, Hideyuki Ohzawa, Hironori Yamaguchi, Hideyo Miyato, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama

Summary: The study showed that the detection of tumor cells in ascites or peritoneal lavages using flow cytometry is correlated with the progression of peritoneal metastases. Tumor-leukocyte ratio (TLR) is associated with peritoneal cancer index scores and the ratios of different cell types.

CYTOMETRY PART B-CLINICAL CYTOMETRY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group

Sohei Satoi, Naminatsu Takahara, Tsutomu Fujii, Hiroyuki Isayama, Suguru Yamada, Yasushi Tsuji, Hideyo Miyato, Hironori Yamaguchi, Tomohisa Yamamoto, Daisuke Hashimoto, So Yamaki, Yousuke Nakai, Kei Saito, Hayato Baba, Toru Watanabe, Shigeto Ishii, Masamichi Hayashi, Keisuke Kurimoto, Hideaki Shimada, Joji Kitayama

Summary: This article reviews the clinical diagnosis and treatment of pancreatic ductal adenocarcinoma with peritoneal dissemination and provides recommendations based on clinical questions. The guideline evaluates the quality and evidence of the literature using the GRADE System and provides guidance on diagnostic, chemotherapeutic, and surgical approaches.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2022)

添加到收藏夹

Article Multidisciplinary Sciences

MiR-29b may suppresses peritoneal metastases through inhibition of the mesothelial-mesenchymal transition (MMT) of human peritoneal mesothelial cells

Yuki Kimura, Hideyuki Ohzawa, Hideyo Miyato, Yuki Kaneko, Akira Saito, Kazuya Takahashi, Mineyuki Tojo, Hironori Yamaguchi, Kentaro Kurashina, Shin Saito, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama

Summary: Peritoneal dissemination, a major metastatic pathway for gastrointestinal and ovarian malignancies, is influenced by the downregulation of miR-29b in peritoneal fluids. Through in vitro experiments, it was found that miR-29b inhibits TGF-beta 1 induced mesothelial-mesenchymal transition (MMT) and has a regulatory effect on mesothelial cells. MiR-29b may be a potential therapeutic target for preventing the development of peritoneal metastases.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Oncology

Preoperative Osteopenia Is Associated with Significantly Shorter Survival in Patients with Perihilar Cholangiocarcinoma

Jun Watanabe, Atsushi Miki, Yasunaru Sakuma, Kentaro Shimodaira, Yuichi Aoki, Yoshiyuki Meguro, Kazue Morishima, Kazuhiro Endo, Hideki Sasanuma, Alan Kawarai Lefor, Takumi Teratani, Noriyoshi Fukushima, Joji Kitayama, Naohiro Sata

Summary: This study aimed to evaluate whether osteopenia is a prognostic factor in patients with perihilar cholangiocarcinoma. The study found that osteopenia is associated with significantly shorter survival in patients with perihilar cholangiocarcinoma, and preoperative osteopenia may be a useful tool for predicting prognosis in these patients.

CANCERS (2022)

添加到收藏夹

Article Environmental Sciences

Effect of Oral Administration of Lactiplantibacillus plantarum SNK12 on Temporary Stress in Adults: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study

Takumi Watanabe, Kyoko Hayashi, Tsuyoshi Takara, Takumi Teratani, Joji Kitayama, Toshio Kawahara

Summary: Studies in mice have shown that Lactiplantibacillus plantarum SNK12 (SNK) has anti-stress effects, increasing neurotrophic factor and gamma-aminobutyric acid receptor levels in the hippocampus and improving depressive behavior. In this study, SNK ingestion was found to reduce stress levels, negative feelings, and stress-related markers in healthy adults.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

添加到收藏夹

Article Oncology

Novel Drug Delivery Method Targeting Para-Aortic Lymph Nodes by Retrograde Infusion of Paclitaxel into Pigs' Thoracic Duct

Akira Saito, Natsuka Kimura, Yuji Kaneda, Hideyuki Ohzawa, Hideyo Miyato, Hironori Yamaguchi, Alan Kawarai Lefor, Ryozo Nagai, Naohiro Sata, Joji Kitayama, Kenichi Aizawa

Summary: This study investigated the efficiency of delivering anticancer drugs directly to intra-abdominal lymph nodes by retrograde administration through the thoracic duct. The results showed that thoracic infusion achieved higher drug doses in the lymph nodes compared to systemic administration. This method may have clinical benefits for patients with extensive lymphatic metastases in abdominal malignancies.

CANCERS (2022)

添加到收藏夹

Article Oncology

Intraperitoneal transfer of microRNA-29b-containing small extracellular vesicles can suppress peritoneal metastases of gastric cancer

Yuki Kimura, Hideyuki Ohzawa, Hideyo Miyato, Yuki Kaneko, Takahiro Kuchimaru, Rei Takahashi, Hironori Yamaguchi, Kentaro Kurashina, Shin Saito, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama

Summary: Small extracellular vesicles (sEV) containing miR-29b can suppress the development of peritoneal metastases (PM) in a murine model of gastric cancer.

CANCER SCIENCE (2023)

添加到收藏夹

Article Medicine, General & Internal

Simulator Fidelity Does Not Affect Training for Robot-Assisted Minimally Invasive Surgery

Shin Saito, Kazuhiro Endo, Yasunaru Sakuma, Naohiro Sata, Alan Kawarai Lefor

Summary: This study compared performance using a surgical robot after training with different fidelity simulators. The results showed significant differences in time and GEARS scores among the different simulators. The conclusion is that training with simulators of varying fidelity can achieve similar performance using the da Vinci robot.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review

Akira Saito, Joji Kitayama, Ryozo Nagai, Kenichi Aizawa

Summary: Despite progress in developing anti-cancer agents, systemic chemotherapy for solid tumors leads to insufficient drug uptake by targeted tumor tissue and often damages healthy organs. Local administration of anti-cancer agents offers a strategy to increase drug concentrations in tumor tissue while reducing systemic toxicity. However, the survival benefits of this approach are limited. This review analyzes clinical results and discusses future directions for regional cancer therapy with local administration of chemotherapy.

PHARMACEUTICS (2023)

添加到收藏夹

Article Oncology

Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma

Atsushi Miki, Yasunaru Sakuma, Jun Watanabe, Kazuhiro Endo, Hideki Sasanuma, Takumi Teratani, Alan Kawarai Lefor, Joji Kitayama, Naohiro Sata

Summary: This study evaluated the impact of osteopenia on survival in patients with intrahepatic cholangiocarcinoma (ICC) undergoing hepatectomy. The results showed that osteopenia was a significant independent factor associated with postoperative survival in patients with ICC.

CURRENT ONCOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer

Yuko Kumagai, Yurie Futoh, Hideyo Miyato, Hideyuki Ohzawa, Hironori Yamaguchi, Shin Saito, Kentaro Kurashina, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama

Summary: The study demonstrates that PD-1 antibody therapy can alter the immune composition of peritoneal tumors, reducing peritoneal metastases in patients with metastatic gastric cancer, potentially prolonging patients' survival.

IN VIVO (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.